0001209191-19-044613.txt : 20190805
0001209191-19-044613.hdr.sgml : 20190805
20190805170255
ACCESSION NUMBER: 0001209191-19-044613
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190802
FILED AS OF DATE: 20190805
DATE AS OF CHANGE: 20190805
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Witz Pascale
CENTRAL INDEX KEY: 0001703723
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 19999436
MAIL ADDRESS:
STREET 1: C/O REGULUS THERAPEUTICS INC.
STREET 2: 10614 SCIENCE CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: Horizon Pharma plc
DATE OF NAME CHANGE: 20140919
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-08-02
0
0001492426
Horizon Therapeutics Public Ltd Co
HZNP
0001703723
Witz Pascale
C/O HORIZON THERAPEUTICS PLC
CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD
DUBLIN
L2
4
IRELAND
1
0
0
0
Ordinary Shares
2019-08-02
4
M
0
8203
A
23499
I
By Trust
Ordinary Shares
2019-08-02
4
F
0
3220
24.64
D
20279
I
By Trust
Restricted Stock Units
2019-08-02
4
M
0
8203
0.00
D
Ordinary shares
8203
8204
D
Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
The shares subject to the restricted stock units vest in three equal annual installments on the anniversary of the grant date (August 2, 2017).
/s/ Miles W. McHugh, Attorney-in-Fact
2019-08-05